Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment (Q24236638)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment (English)

0 references

1 reference

Fiona Kew

1

0 references

Khadra Galaal

series ordinal

2

0 references

Andrew Bryant

series ordinal

3

0 references

Raj Naik

series ordinal

4

0 references

language of work or name

English

0 references

publication date

2011

0 references

published in

0 references

issue

6

0 references

page(s)

CD006119

0 references

cites work

Grading quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

19 March 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

ACR Appropriateness Criteria on staging and follow-up of ovarian cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

The role of routine follow-up after gynecological malignancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

The follow-up of ovarian cancer.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Role of chest CT in the follow-up of ovarian adenocarcinoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Routine follow up of breast cancer in primary care: randomised trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long-term followup of female genital cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Clinical correlations of carcinoembryonic antigen in post-operative patients with epithelial ovarian cancer

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Ovarian carcinoma follow-up: US versus laparotomy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

The predictive value of a combination of tumor markers in monitoring patients with ovarian cancer.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Assessment of ovarian tumors by transvaginal scanning and clinical significance of ultrasonic examination in postoperative follow up

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Predictive value of serial carcinoembryonic antigen levels in long-term follow-up of ovarian cancer

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

What are the factors associated with the follow-up preferences of women in long-term remission from gynaecological cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Clinical value of positron emission tomography with FDG for recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Value of chest CT scans in routine ovarian carcinoma follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

The role of regular physical examination in the detection of ovarian cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006119.PUB2

PET-CT in recurrent ovarian cancer: impact on treatment planning

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

[The value of FDG PET/CT, ultrasound and CT in diagnosing recurrent ovarian carcinoma].

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Routine follow-up after treatment for a gynecological cancer: a survey of practice

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

The views of ovarian cancer survivors on its cause, prevention, and recurrence.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171123

[Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K]

29 November 2018

1 reference

12 December 2020

Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels

1 reference

12 December 2020

The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer

1 reference

12 December 2020

Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients

1 reference

12 December 2020

Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer

1 reference

12 December 2020

Use of CA 125 in follow-up of ovarian cancer

1 reference

12 December 2020

Role of computed abdominal tomography (C.A.T. Scan) in the follow up of ovarian tumors

1 reference

12 December 2020

[Clinical usefulness of serum sialyl Le(x)-i measurement in patients with ovarian cancer]

1 reference

12 December 2020

[Feasibility of peritoneal washing cytology through the totally implanted reservoir for early detection of peritoneal recurrence of ovarian cancer]

1 reference

12 December 2020

[Validity of Gynaegnost in the follow-up of patients treated for ovarian cancer]

1 reference

12 December 2020

Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy

1 reference

12 December 2020

Ultrasonographic-guided pervaginal cul-de-sac cytology in the follow-up of ovarian carcinoma

1 reference

12 December 2020

Clinical surveillance of gynecologic cancer patients

1 reference

12 December 2020

CA-125 monitoring in the management of ovarian cancer

1 reference

12 December 2020

CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer

1 reference

12 December 2020

[Tissue polypeptide antigen as a tumor marker for gynecologic malignancies]

1 reference

12 December 2020

[Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer. CA 125 as a tumor marker. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)]

1 reference

12 December 2020

Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer

1 reference

12 December 2020

The value of follow-up in stage II carcinoma of the cervix

1 reference

12 December 2020

The role of sonographic examination in the follow-up of gynecological neoplasms

1 reference

12 December 2020

[Significance of immunosuppressive acidic protein in the diagnosis and follow-up of patients with ovarian cancer, in particular as a marker for chemotherapeutic effects]

1 reference

12 December 2020

Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination--a longitudinal study

1 reference

12 December 2020

Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma

1 reference

12 December 2020

Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer

1 reference

12 December 2020

A study to evaluate the use of CA125 in ovarian cancer follow-up: A change in practice led by patient preference

1 reference

12 December 2020

[Abdominal computerized tomography in the after-care of ovarian cancers]

1 reference

12 December 2020

CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer

1 reference

12 December 2020

Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study

1 reference

12 December 2020

Follow-up study of ovarian carcinoma by cytology of cul-de-sac aspirates

1 reference

12 December 2020

The Role of Cul-de-Sac Aspiration Cytology in the Follow-up of Ovarian Cancer

1 reference

12 December 2020

Follow-up laparoscopy in patients with ovarian cancer

1 reference

12 December 2020

Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer

1 reference

12 December 2020

Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up

1 reference

12 December 2020

Tumor marker CA 125 in diagnosis, monitoring management and follow-up of patients with ovarian tumors

1 reference

12 December 2020

Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

12 December 2020

Follow-up of patients with gynaecological cancer

1 reference

12 December 2020